{"schema_version":"secwatch.filing_event.v1","accession":"0001822479-26-000028","form_type":"8-K","ticker":"SHC","cik":"0001822479","company_name":"Sotera Health Co","filed_at":"2026-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.012708+00:00","generated_at":"2026-05-14T23:32:01.643403+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sotera Health reports Q1 2026 results and announces CEO transition","bullets":["Q1 net revenues up 10.0% (6.5% constant currency); net income $27M vs loss $13M in prior year.","Adjusted EBITDA increased 10.5% (6.9% constant currency); Adjusted EPS $0.18, up 29%.","Michael Petras appointed Executive Chairman; Alton Shader named CEO effective May 26, 2026.","Reaffirmed 2026 outlook: net revenue growth 5.0%-6.5% and Adj. EBITDA growth 5.5%-7.0% constant currency.","Added independent directors Rich Kyle and Ken Krause to Board; public float ~90%."],"urls":{"canonical":"https://secwatch.observer/filing/0001822479-26-000028","json":"https://secwatch.observer/filing/0001822479-26-000028.json","markdown":"https://secwatch.observer/filing/0001822479-26-000028.md","text":"https://secwatch.observer/filing/0001822479-26-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822479/000182247926000028/0001822479-26-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822479/000182247926000028/shc-20260430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-14T23:32:01.643403+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ae75b73dfe190558dfd51d0363717be6fe8e90ac","claim":"Sotera Health Co reported the quarter ended March 31, 2026 results: net income net income of $27 million, EPS $0.09 per diluted share. Guidance reaffirmed.","evidence_excerpt":"Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025 • Q1 2026 Adjusted EBITDA (1) increased 10.5%, or 6.9% on a constant currency basis • Q1 2026 Adjusted EPS (1) of $0.18 , an increase of 29% per diluted share • Company reaffirms full-year 2026 outlook of 5.0% - 6.5% net revenues growth and 5.5% - 7.0% Adjusted EBITDA growth, both on a constant currency basis","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822479/000182247926000028/0001822479-26-000028-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"Net income","value":"net income of $27 million"},{"label":"EPS","value":"$0.09 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"3aaceb885c","claim":"Michael B. Petras, Jr. was appointed as Executive Chairman of the Board at Sotera Health Co.","evidence_excerpt":"the Board appointed Mr. Petras to serve as Executive Chairman of the Board (\"Executive Chairman\"), as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822479/000182247926000028/0001822479-26-000028-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"95390199e5","claim":"Alton Shader was appointed as Chief Executive Officer at Sotera Health Co.","evidence_excerpt":"the Board, at the recommendation of the Nominating and Corporate Governance Committee, appointed Alton Shader to serve as Chief Executive Officer of the Company (\"CEO\") and a Class II director of the Board, effective as of May 26, 2026","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822479/000182247926000028/0001822479-26-000028-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"b8a2b9f20f","claim":"Alton Shader was appointed as Class II director at Sotera Health Co.","evidence_excerpt":"appointed Alton Shader to serve as Chief Executive Officer of the Company (\"CEO\") and a Class II director of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1822479/000182247926000028/0001822479-26-000028-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}